A Safety, Tolerability and PK Study of DCC-2618 in Patients With Advanced Malignancies

Leiden University Medical Center (GIST and other solid tumors), Leiden

Colombia University Medical Center (mastocytosis), New York

Memorial Sloan Kettering Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors), New York

HELIOS Klinikum Berlin-Buch (GIST, and other solid tumors), Berlin

Fox Chase Cancer Center (GIST only), Philadelphia

Virginia Commonwealth University School of Medicine (mastocytosis), Richmond

Mayo Clinic (GIST, mastocytosis, glial malignancies, other solid tumors), Jacksonville

University of Miami (GIST, mastocytosis, glial malignancies, other solid tumors), Miami

University Hospital of Verona (mastocytosis), Verona

Essen University Hospital (mastocytosis, GIST, and other solid tumors), Essen

Uniklinik RWTH Aachen (mastocytosis, GIST, and other solid tumors), Aachen

University Medical Centre Mannheim (mastocytosis), Mannheim

MD Anderson Cancer Center (GIST, mastocytosis, glial malignancies, other solid tumors), Houston

Freiburg University Hospital (mastocytosis, and other solid tumors), Freiburg im Breisgau

Huntsman Cancer Institute (GIST, mastocytosis, glial malignancies, other solid tumors), Salt Lake City

Honor Health (GIST, mastocytosis, other solid tumors), Scottsdale

UCLA Hematology Center (mastocytosis), Los Angeles

UCLA (glial malignancies only), Los Angeles

UCSF (glial malignancies only), San Francisco

Stanford University Comprehensive Cancer Center (GIST), Palo Alto

Stanford University Hematology Clinic (mastocytosis), Palo Alto

OHSU (GIST & mastocytosis only), Portland

Dana Farber Cancer Institute (GIST, mastocytosis, glial malignancies, other solid tumors), Boston

Princess Margaret Cancer Centre (GIST, other solid tumors), Toronto

Guy's Hospital (mastocytosis only), London

Royal Marsden Hospital (GIST, glial malignancies, other solid tumors), London